Cefotaxime Dosing for Typhoid Fever
For uncomplicated typhoid fever, cefotaxime should be dosed at 80 mg/kg/day IV (maximum 2 grams every 6-8 hours) for 5-7 days in children, and 2 grams IV every 6-8 hours for adults, with dose reduction to 50% in severe renal impairment (creatinine clearance <20 mL/min). 1, 2
Standard Dosing Regimens
Children (1 month to 12 years)
- Recommended dose: 80 mg/kg/day IV as a single daily dose for 5-7 days 1
- For children weighing ≥50 kg, use adult dosing
- Maximum daily dose should not exceed 12 grams 2
Adults
- Standard dose: 2 grams IV every 6-8 hours 2
- For uncomplicated infections: 1 gram every 12 hours IM or IV 2
- For moderate to severe infections: 1-2 grams every 8 hours 2
- Maximum daily dosage: 12 grams 2
Neonates (birth to 1 month)
- 0-1 week of age: 50 mg/kg per dose every 12 hours IV 2
- 1-4 weeks of age: 50 mg/kg per dose every 8 hours IV 2
Renal Impairment Adjustments
Critical dosing modification is required in severe renal dysfunction to prevent accumulation of both cefotaxime and its active metabolite, desacetyl cefotaxime.
Dose Reduction Guidelines
- Creatinine clearance <20 mL/min/1.73 m²: Reduce dose by 50% 2
- Creatinine clearance 3-10 mL/min: Consider 0.5 g twice daily 3
- Severe renal impairment: Half-life increases from 1.0 hour to 2.6 hours for cefotaxime and from 1.5 hours to 10.0 hours for the metabolite 3
Calculating Creatinine Clearance
When only serum creatinine is available 2:
- Males: [Weight (kg) × (140 - age)] / (72 × serum creatinine)
- Females: 0.85 × male calculation
Important Considerations
- The desacetyl metabolite accumulates significantly more than the parent drug in renal failure 4, 3
- In end-stage renal disease requiring hemodialysis, terminal half-life of desacetyl cefotaxime extends to 23.15 hours 4
- Monitor blood counts if treatment exceeds 10 days 2
Treatment Duration and Clinical Context
Duration
- Minimum: 5-7 days for uncomplicated typhoid 1
- Continue for 48-72 hours after defervescence 2
- One clinical trial showed average defervescence on day 7 (range 3-14 days) with total dose averaging 31 grams 5
Clinical Efficacy
Cefotaxime is particularly valuable as a second-line agent for typhoid fever when fluoroquinolone resistance is present 1. The WHO Pocket Book recommends ceftriaxone (a closely related third-generation cephalosporin) at 80 mg/kg/day for 5-7 days as second-line therapy 1, and cefotaxime provides comparable antimicrobial coverage with similar dosing.
Common Pitfalls
- Do not use first-generation cephalosporins (e.g., cephalexin) as they are inactive against Salmonella typhi 6
- Avoid underdosing in children >20 kg—the 50 mg/kg dose may be insufficient for typhoid; use 80 mg/kg/day 1
- In regions with high fluoroquinolone resistance (>70% of isolates in some areas), cefotaxime/ceftriaxone should be considered first-line rather than ciprofloxacin 7
- Probenecid reduces cefotaxime clearance by 50%; avoid doses >6 grams/day if co-administered 2